Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02415881
Title Phase I Panitumumab IRDye800 Optical Imaging Study
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eben Rosenthal
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35294 United States Details
Stanford University, School of Medicine Stanford California 94305 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field